DE69213729D1 - Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte - Google Patents

Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte

Info

Publication number
DE69213729D1
DE69213729D1 DE69213729T DE69213729T DE69213729D1 DE 69213729 D1 DE69213729 D1 DE 69213729D1 DE 69213729 T DE69213729 T DE 69213729T DE 69213729 T DE69213729 T DE 69213729T DE 69213729 D1 DE69213729 D1 DE 69213729D1
Authority
DE
Germany
Prior art keywords
polymer
molecular weights
different molecular
dosage containing
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69213729T
Other languages
English (en)
Other versions
DE69213729T2 (de
Inventor
Jeri D Wright
Brian L Barclay
David R Swanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69213729D1 publication Critical patent/DE69213729D1/de
Application granted granted Critical
Publication of DE69213729T2 publication Critical patent/DE69213729T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
DE69213729T 1991-04-22 1992-04-22 Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte Expired - Fee Related DE69213729T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/688,807 US5208037A (en) 1991-04-22 1991-04-22 Dosage forms comprising polymers comprising different molecular weights
PCT/US1992/003294 WO1992018102A1 (en) 1991-04-22 1992-04-22 Dosage forms comprising polymers comprising different molecular weights

Publications (2)

Publication Number Publication Date
DE69213729D1 true DE69213729D1 (de) 1996-10-17
DE69213729T2 DE69213729T2 (de) 1997-01-30

Family

ID=24765867

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69213729T Expired - Fee Related DE69213729T2 (de) 1991-04-22 1992-04-22 Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte

Country Status (17)

Country Link
US (2) US5208037A (de)
EP (1) EP0581862B1 (de)
JP (1) JP2638303B2 (de)
KR (1) KR0158466B1 (de)
AT (1) ATE142481T1 (de)
AU (1) AU655827B2 (de)
CA (1) CA2101245C (de)
DE (1) DE69213729T2 (de)
ES (1) ES2092115T3 (de)
FI (1) FI110160B (de)
IE (1) IE921269A1 (de)
MX (1) MX9201813A (de)
NO (1) NO306976B1 (de)
NZ (1) NZ242419A (de)
PT (1) PT100417B (de)
WO (1) WO1992018102A1 (de)
ZA (1) ZA922907B (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
ES2168610T3 (es) * 1996-03-12 2002-06-16 Alza Corp Composicion y forma galenica que contiene un antagonista opioide.
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
EP0946151B1 (de) * 1996-11-25 2006-05-10 Alza Corporation Dosisform mit ansteigender dosisfreisetzung
EP1782798A3 (de) 1996-11-25 2008-05-21 Alza Corporation Darreichungsform mit ansteigender Dosisfreisetzung
ZA979605B (en) * 1996-11-25 1998-05-21 Alza Corp Ascending-dose dosage form.
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
WO2001056543A1 (en) 2000-02-04 2001-08-09 Alza Corporation Osmotically-driven fluid dispenser and coating composition
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US20040001886A1 (en) * 2001-10-17 2004-01-01 Dr. Reddy's Laboratories Limited Stabilized pharmaceutical formulations containing amlodipine maleate
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20100010336A1 (en) * 2002-02-07 2010-01-14 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including attention deficit hyperactivity disorder (adhd), autism, and schizophrenia
US20050272812A1 (en) * 2002-02-07 2005-12-08 Pettegrew Jay W Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
JP2005523269A (ja) * 2002-02-07 2005-08-04 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 老人性うつ病の治療におけるカルニチン
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US8894973B2 (en) * 2002-02-07 2014-11-25 Jay W. Pettegrew Method and system for differential diagnosis of chronic schizophrenia and chronic alcoholism
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
HUE038446T2 (hu) 2002-09-20 2018-10-29 Alpharma Pharmaceuticals Llc Szekvesztráló alegység és releváns kompozíciók és módszerek
US20050112087A1 (en) * 2003-04-29 2005-05-26 Musso Gary F. Pharmaceutical formulations for sustained drug delivery
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US7687239B2 (en) 2003-07-12 2010-03-30 Accelrs Technology Corporation Sensitive and rapid determination of antimicrobial susceptibility
EP2484346B1 (de) 2006-06-19 2017-02-22 Alpharma Pharmaceuticals LLC Pharmazeutische Zusammensetzungen
CN100563637C (zh) * 2006-10-13 2009-12-02 北京红林制药有限公司 一种控释给药的药芯组合物和控释制剂及其制备方法
CN100563638C (zh) * 2006-10-24 2009-12-02 北京红林制药有限公司 硝苯地平控释片及其制备方法
DK2200588T3 (da) 2007-09-25 2019-07-01 Solubest Ltd Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2012071220A1 (en) * 2010-11-23 2012-05-31 Transcept Pharmaceuticals, Inc. Compositions and methods for once-daily administration of a trilayer osmotic tablet
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
ES2551922T3 (es) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Sistemas rápidos de purificación celular
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
WO2015085312A1 (en) 2013-12-06 2015-06-11 Durect Corporation Compositions comprising antioxidant, fluid dispensers, and methods involving the same
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10023895B2 (en) 2015-03-30 2018-07-17 Accelerate Diagnostics, Inc. Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing
EP3364955B1 (de) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmazeutische formulierung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB2140487B (en) * 1983-05-25 1987-03-11 Baker Ham & Co Ltd Improvements relating to penstocks
US4717566A (en) * 1984-03-19 1988-01-05 Alza Corporation Dosage system and method of using same
US4863456A (en) * 1986-04-30 1989-09-05 Alza Corporation Dosage form with improved delivery capability
US4743248A (en) * 1986-08-11 1988-05-10 Alza Corporation Dosage form for delivering acid sensitive beneficial agent
US4946687A (en) * 1987-10-02 1990-08-07 Alza Corporation Dosage form for treating cardiovascular diseases
US4950486A (en) * 1987-10-02 1990-08-21 Alza Corporation Dosage form for treating cardiovascular diseases
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US4966769A (en) * 1988-06-02 1990-10-30 Alza Corporation Method for delivering dosage form for diltiazem
US4902514A (en) * 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation

Also Published As

Publication number Publication date
PT100417B (pt) 1999-06-30
NO933728L (no) 1993-10-18
NZ242419A (en) 1994-07-26
AU1917392A (en) 1992-11-17
KR0158466B1 (ko) 1998-12-01
ES2092115T3 (es) 1996-11-16
CA2101245A1 (en) 1992-10-23
MX9201813A (es) 1992-10-01
PT100417A (pt) 1993-08-31
US5326571A (en) 1994-07-05
EP0581862B1 (de) 1996-09-11
US5208037A (en) 1993-05-04
FI934653A0 (fi) 1993-10-21
CA2101245C (en) 2002-06-25
ZA922907B (en) 1993-02-24
FI110160B (fi) 2002-12-13
ATE142481T1 (de) 1996-09-15
NO306976B1 (no) 2000-01-24
JPH06506952A (ja) 1994-08-04
AU655827B2 (en) 1995-01-12
EP0581862A1 (de) 1994-02-09
JP2638303B2 (ja) 1997-08-06
WO1992018102A1 (en) 1992-10-29
FI934653A (fi) 1993-10-21
DE69213729T2 (de) 1997-01-30
IE921269A1 (en) 1992-11-04

Similar Documents

Publication Publication Date Title
DE69213729D1 (de) Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte
FR2674747B1 (fr) Dispositif distributeur de gouttes de petit volume, notamment pour soins ophtalmologiques.
IL103981A (en) CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS
FI913248A (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
DE69223902T2 (de) Antimikrobielle polymerisierbare Zusammensetzung, das Polymer und daraus hergestellter Gegenstand
DE69203632D1 (de) Infusionskatheter.
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
MX9205981A (es) Administracion transdermica de melatonina.
DE59202906D1 (de) Flüssigkristalline Polymere mit nahezu einheitlichem Molekulargewicht.
DE68900126D1 (de) Vinylaromatische verbindungen stabilisiert gegen polymerisation.
DE69112735D1 (de) Stabilisierte Monomerenzusammensetzungen.
NL9101936A (nl) Polymeermengsel en daaruit gevormde voorwerpen.
IT9021718A0 (it) Stabilizzanti u.v. siliconici contenenti gruppi reattivi
BR9201398A (pt) Emprego de oligouretanas com pesos moleculares de 5.000 ate 50.000
DE59101655D1 (de) Regelvorrichtung zur Regelung der Fördervolumeneinstellung mehrerer hydrostatischer Pumpen.
NO179504C (no) Legemiddel i form av en tablett inneholdende diritromycin
DE69108020T2 (de) Polymerzusammensetzung, und daraus hergestellte Formkörper.
BR9201397A (pt) Emprego de oligouretanas com pesos moleculares de 5.000 a 50.000
IT1248073B (it) Composti polimerici, contenenti gruppi amminici ingombrati stericamente, adatti come stabilizzanti e composizioni polimeriche comprendenti gli stessi.
DK532189A (da) Rulleholder, udleveringsbeholder
FR2703150B1 (fr) Dispositif de dosage, notamment pour produits visqueux.
JPS5223144A (en) Polymer composition stabilised against ultraviolet rays
CO4600721A1 (es) Nueva formulacion agroquimica
DE3263985D1 (en) Polymer stabilising compositions, polymers stabilised therewith and shaped articles formed from such polymers
MX9704847A (es) Material de relleno para forma de dosis farmaceutica de gelatina blanda.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee